Campbell & Co. Investment Adviser »

Arcutis Biotherapeutics shares owned by Campbell & Co. Investment Adviser

Quarter-by-quarter ownership of Arcutis Biotherapeutics (ARQT) shares owned by Campbell & Co. Investment Adviser from 13F filings

Historical chart of Campbell & Co. Investment Adviser investment in Arcutis Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Arcutis Biotherapeutics held by Campbell & Co. Investment Adviser consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arcutis Biotherapeutics by Campbell & Co. Investment Adviser

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.1M 76k 13.93
2024-09-30 $703k 76k 9.30

More positions owned by Campbell & Co. Investment Adviser

Intercontinental Exchange In Common Stock (ICE)
Fastenal Common Stock (FAST)
Novartis Adr (NVS)
Hca Healthcare Common Stock (HCA)
Schwab Charles Corp Common Stock (SCHW)
Electronic Arts Common Stock (EA)
Elevance Health Common Stock (ELV)
Grainger W W Common Stock (GWW)
Packaging Corp Amer Common Stock (PKG)
Roper Technologies Common Stock (ROP)
Mondelez Intl Common Stock (MDLZ)
Aflac Common Stock (AFL)
Applied Matls Common Stock (AMAT)
Marketaxess Hldgs Common Stock (MKTX)
Ameriprise Finl Common Stock (AMP)

View all positions for Campbell & Co. Investment Adviser

Top funds holding Arcutis Biotherapeutics

Jennison Associates
Suvretta Capital Management
Rubric Capital Management
BlackRock
Frazier Life Sciences Management
Polar Capital Holdings
Vanguard Group
State Street Corporation
Morgan Stanley
Gilder, Gagnon, Howe & Co
Franklin Resources
UBS Group
D. E. Shaw & Co
Geode Capital Management
Ensign Peak Advisors

View all funds holding Arcutis Biotherapeutics